Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Kraft Milestone and Contract

5 Oct 2009 07:00

RNS Number : 1756A
TyraTech, Inc.
05 October 2009
Β 

ο»Ώ

For Immediate Release

5 OctoberΒ 2009

TYRATECH, INC.

("TyraTech" or "the Company")

Completion of Second Kraft Foods MilestoneΒ 

and

Revised Contract

~ Revised contract for the remainder of the development project ~Β 

TyraTech, Inc. (AIM: TYR), a leading independent novel eco-technology company for human, animal and environmental health, is pleased to announce thatΒ it has successfully achieved the second milestone in its functional foods contract withΒ Kraft Foods Holdings, IncΒ ("Kraft Foods",Β NYSE: KFT),Β the world's second largest food company andΒ aΒ globalΒ leader in the consumer food products sector. In addition, with the project moving forward, the companies have revised the functional foods contract (the "Contract") to better address the development plan. The balance of the second milestone will be paid immediately, and under the revised Contract, TyraTech will receive a bi-annual cost reimbursement for agreed upon development costs for what would have been stages three and four.

In December 2006,Β TyraTechΒ signed a worldwide exclusive co-development agreement with KraftΒ Foods toΒ develop new, functional-food products to benefit people living in areas with endemic parasitic disease. This agreement was amended in December 2008. As expected at the time of the interim results on 16 September, TyraTech hasΒ completedΒ the secondΒ stage of the agreementΒ this year, triggering the remainder of its milestone payment to be paid immediately. The remaining two exclusivity payments for stages three and four will be paid at the end of this year and during 2011.Β 

Whilst stage two remains unchanged andΒ TyraTech will continue to receive an exclusivity fee from Kraft Foods for each stage, stages three and four have been amended under the revised contract in that TyraTech will now receive reimbursement of agreed upon development costs bi-annually.Β KraftΒ FoodsΒ retains the abilityΒ toΒ recover certain development costs fromΒ future productΒ royalties.Β TyraTech also reported in its interim results that it had already commencedΒ work onΒ stage three, which will involve theΒ furtherΒ qualification of the lead product.Β 

Commenting on theΒ revised contract,Β Douglas Armstrong, Chief Executive OfficerΒ of TyraTech, said:

"TyraTech and Kraft Foods have together made significant progress on this innovative functional food project. The continued evolution of our partnership with Kraft Foods demonstrates not only the strength of our relationship, but also the potential of our technology."

For further information please contact:

TyraTech Inc.

Douglas Armstrong Ph.D., Chief Executive Officer +1 (321) 409 7723

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker/Clare Terlouw +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

Lisa Baderoon/ +44 (0)20 7466 5000 Catherine Breen / Stasa Filiplic

www.buchanan.uk.com

About TyraTech TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech,Β which already has productsΒ on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's Nature's Technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors. TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for consumer and professional pest control. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections. TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visitΒ www.tyratech.comΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTCKBKBQBDDDKK
Date   Source Headline
14th Jan 20147:00 amRNSChange of Adviser
14th Jan 20147:00 amRNSVamousse coming to Walmart stores in the USA
18th Dec 20137:00 amRNSBlocklisting Interim Review
25th Oct 20132:39 pmRNSDirector/PDMR Shareholding
7th Oct 20138:39 amRNSDirector/PDMR Shareholding
30th Sep 20137:00 amRNSInterim Results
14th Aug 20137:00 amRNSGlobal distribution agreement for biocide products
25th Jul 20136:11 pmRNSResult of AGM
27th Jun 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSDirectorate Changes
19th Jun 20139:59 amRNSBlocklisting Interim Review
11th Jun 20134:23 pmRNSDirectorate Change
31st May 201312:43 pmRNSMigration of Shares
11th Apr 20137:00 amRNSFrench Registration of Insect Repellent Product
9th Apr 20137:00 amRNSHolding(s) in Company
28th Mar 20136:09 pmRNSResult of Special Meeting
28th Mar 20134:15 pmRNSShare Migration
19th Mar 20137:00 amRNSAppointment of Financial PR and IR advisor
18th Mar 20137:00 amRNSProposed placing and subscription of common shares
4th Mar 20137:00 amRNSUK registration of insect repellent product
4th Feb 20137:00 amRNSFirst Patent Granted for ExtendT Technology
30th Jan 20137:00 amRNSAMVAC and TyraTech Name New Joint Venture
10th Jan 20137:00 amRNSDirectorate Change
7th Jan 201310:40 amRNSNew Anti-Endoparasitic Composition Patents
20th Dec 20127:00 amRNSIssue of Equity
18th Dec 20122:56 pmRNSBlocklisting Interim Review
18th Dec 20127:00 amRNSGerman Registration of Insect Repellent Product
17th Dec 20127:00 amRNSFirst Shipment of Retail Products
11th Dec 20127:00 amRNSHead Lice Product Registration in UK
4th Dec 20127:00 amRNSFormation of New Joint Venture
13th Nov 20127:00 amRNSU.S. Registration of New Insect Repellent Product
7th Nov 20122:10 pmRNSProactive Investors One2One Investor Forum
30th Oct 20127:00 amRNSAdvance Payment on Prospective New Alliance
29th Oct 20127:00 amRNSChange of Name of Adviser
16th Oct 201211:40 amRNSTyraTech Secures New Patent
16th Oct 20129:26 amRNSMigration of Shares
1st Oct 20127:00 amRNSInterim Results
28th Sep 20121:15 pmRNSInterim Results
26th Sep 20127:00 amRNSProducts to Launch at The Home Depot
25th Sep 20127:00 amRNSTrademark Licensing Agreement with Terminix
10th Aug 20123:02 pmRNSMigration of Shares
25th Jul 20123:55 pmRNSResult of AGM
6th Jul 20124:36 pmRNSMigration of Shares
2nd Jul 20121:18 pmRNSDirector/PDMR Shareholding
2nd Jul 201211:39 amRNSDirector/PDMR Shareholding
28th Jun 20127:00 amRNSFinal Results
18th Jun 20127:00 amRNSBlocklisting Interim Review
22nd May 20127:00 amRNSTrading Update
14th May 20127:00 amRNSIssue of Equity
10th May 20127:00 amRNSMigration of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.